Breastfeeding Evaluation of Puerperal Women Who Had Cesarean Delivery in Our Hospital
Launched by KONYA CITY HOSPITAL · Nov 8, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how different methods of pain relief after a cesarean delivery can affect breastfeeding for new mothers. The researchers want to understand if a specific pain relief technique called TAP block can help mothers feel better and make it easier for them to start breastfeeding their babies. The World Health Organization recommends that babies should be exclusively breastfed for at least six months because it’s very beneficial for their health and development.
To participate in this trial, women aged 18 to 45 who are scheduled for an elective cesarean delivery and expect to stay in the hospital for at least three nights may be eligible. Participants will need to be able to use a special system that allows them to manage their own pain relief after surgery. Throughout the trial, mothers can expect support in their breastfeeding journey while receiving effective pain management. This study is important because it aims to find ways to improve the breastfeeding experience for mothers who have had cesarean births, which can often be more challenging than for those who have vaginal deliveries.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Written informed consent;
- • 18-45 years old;
- • ASA Physical Status 1-3;
- • Scheduled for elective cesarien delivery;
- • Anticipated hospitalization of at least three nights;
- • Expected requirement for parenteral opioids for at least 72 hours for postoperative pain;
- • Able to use IV PCA systems.
- Exclusion Criteria:
- • Hepatic disease, e.g. twice the normal levels of liver enzymes;
- • Kidney disease, e.g. twice the normal level of serum creatinine;
- • Bupivacaine sensitivity or known allergy;
- • Anticoagulants considered to be a contraindication for TAP blocks;
- • Surgeries with high port sites
About Konya City Hospital
Konya City Hospital is a leading healthcare institution dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. With a commitment to excellence in patient care and a focus on collaborative research, the hospital integrates state-of-the-art facilities and a multidisciplinary team of experienced professionals. By participating in clinical trials, Konya City Hospital aims to contribute to the development of new therapies and enhance the understanding of various medical conditions, ultimately benefiting both the local community and the broader medical field.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Konya, , Turkey
Patients applied
Trial Officials
Ramazan Keçeci, Specialist
Principal Investigator
Konya City Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported